{"pmid":32374890,"title":"COVID-19 Convalescent Plasma; Phase 2.","text":["COVID-19 Convalescent Plasma; Phase 2.","Transfusion","Knudson, C Michael","Jackson, J Brooks","32374890"],"journal":"Transfusion","authors":["Knudson, C Michael","Jackson, J Brooks"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374890","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/trf.15842","topics":["Treatment"],"weight":1,"_version_":1666138496366018564,"score":9.490897,"similar":[{"pmid":32313872,"pmcid":"PMC7164882","title":"COVID-19 convalescent plasma transfusion.","text":["COVID-19 convalescent plasma transfusion.","Hematol Transfus Cell Ther","Langhi, Dante Mario","Santis, Gil Cunha De","Bordin, Jose Orlando","32313872"],"journal":"Hematol Transfus Cell Ther","authors":["Langhi, Dante Mario","Santis, Gil Cunha De","Bordin, Jose Orlando"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313872","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.htct.2020.04.003","topics":["Treatment"],"weight":1,"_version_":1666138493511794688,"score":42.41207},{"pmid":32398379,"title":"Convalescent plasma for patients with COVID-19.","text":["Convalescent plasma for patients with COVID-19.","Proc Natl Acad Sci U S A","Zeng, Furong","Chen, Xiang","Deng, Guangtong","32398379"],"journal":"Proc Natl Acad Sci U S A","authors":["Zeng, Furong","Chen, Xiang","Deng, Guangtong"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398379","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1073/pnas.2006961117","topics":["Treatment"],"weight":1,"_version_":1666714494868389888,"score":42.41207},{"pmid":32425365,"pmcid":"PMC7229974","title":"Why should we use convalescent plasma for COVID-19?","text":["Why should we use convalescent plasma for COVID-19?","Eur J Intern Med","Franchini, Massimo","32425365"],"journal":"Eur J Intern Med","authors":["Franchini, Massimo"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425365","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ejim.2020.05.019","keywords":["covid-19","convalescent plasma","passive immunotherapy"],"topics":["Treatment"],"weight":1,"_version_":1667352728856166400,"score":42.41207},{"pmid":32305026,"pmcid":"PMC7146649","title":"Challenges of Convalescent Plasma Therapy on COVID-19.","text":["Challenges of Convalescent Plasma Therapy on COVID-19.","J Clin Virol","Zhao, Qian","He, Yong","32305026"],"journal":"J Clin Virol","authors":["Zhao, Qian","He, Yong"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32305026","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jcv.2020.104358","topics":["Treatment"],"weight":1,"_version_":1666138491066515456,"score":40.29637},{"pmid":32113510,"pmcid":"PMC7128218","title":"Convalescent plasma as a potential therapy for COVID-19.","text":["Convalescent plasma as a potential therapy for COVID-19.","Lancet Infect Dis","Chen, Long","Xiong, Jing","Bao, Lei","Shi, Yuan","32113510"],"journal":"Lancet Infect Dis","authors":["Chen, Long","Xiong, Jing","Bao, Lei","Shi, Yuan"],"date":"2020-03-02T11:00:00Z","year":2020,"_id":"32113510","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1016/S1473-3099(20)30141-9","link_comment_for":"25030060","topics":["Treatment"],"weight":1,"_version_":1666138492844900353,"score":40.29637}]}